Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances Theunissen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Molecular Neurobiology|July 14, 2023
The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral TherapyMegan Dubowsky, Frances Theunissen, Jillian M Carr, et al.
BMC Medicine|January 17, 2022
Short structural variants as informative genetic markers for ALS disease risk and progressionFrances Theunissen, Loren L Flynn, Ryan S Anderton, et al.
International Journal of Molecular Sciences|August 26, 2022
Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?Bradley Roberts, Frances Theunissen, Francis L Mastaglia, et al.
Scientific Reports|August 30, 2022
Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onsetFrances Theunissen, Ryan S Anderton, Frank L Mastaglia, et al.
Translational Neurodegeneration|November 18, 2021
New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosisFrances Theunissen, Phillip K West, Samuel Brennan, et al.
Molecular Neurodegeneration|October 24, 2025
Entering the era of precision medicine to treat amyotrophic lateral sclerosisFrances Theunissen, Loren Flynn, Alfredo Iacoangeli, et al.
Frontiers in Neuroscience|February 22, 2020
Structural Variants May Be a Source of Missing Heritability in sALSFrances Theunissen, Loren L Flynn, Ryan S Anderton, et al.
Scientific Reports|March 19, 2021
The TOMM40 '523' polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson's diseaseMegan C Bakeberg, Madison E Hoes, Anastazja M Gorecki, et al.
Neurology. Genetics|March 19, 2020
Association of a structural variant within the <i>SQSTM1</i> gene with amyotrophic lateral sclerosisJulia Pytte, Ryan S Anderton, Loren L Flynn, et al.
Frontiers in Aging Neuroscience|December 17, 2020
Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's DiseaseAnastazja M Gorecki, Megan C Bakeberg, Frances Theunissen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Molecular Neurobiology|July 14, 2023
The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral TherapyMegan Dubowsky, Frances Theunissen, Jillian M Carr, et al.
BMC Medicine|January 17, 2022
Short structural variants as informative genetic markers for ALS disease risk and progressionFrances Theunissen, Loren L Flynn, Ryan S Anderton, et al.
International Journal of Molecular Sciences|August 26, 2022
Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?Bradley Roberts, Frances Theunissen, Francis L Mastaglia, et al.
Scientific Reports|August 30, 2022
Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onsetFrances Theunissen, Ryan S Anderton, Frank L Mastaglia, et al.
Translational Neurodegeneration|November 18, 2021
New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosisFrances Theunissen, Phillip K West, Samuel Brennan, et al.
Molecular Neurodegeneration|October 24, 2025
Entering the era of precision medicine to treat amyotrophic lateral sclerosisFrances Theunissen, Loren Flynn, Alfredo Iacoangeli, et al.
Frontiers in Neuroscience|February 22, 2020
Structural Variants May Be a Source of Missing Heritability in sALSFrances Theunissen, Loren L Flynn, Ryan S Anderton, et al.
Scientific Reports|March 19, 2021
The TOMM40 '523' polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson's diseaseMegan C Bakeberg, Madison E Hoes, Anastazja M Gorecki, et al.
Neurology. Genetics|March 19, 2020
Association of a structural variant within the <i>SQSTM1</i> gene with amyotrophic lateral sclerosisJulia Pytte, Ryan S Anderton, Loren L Flynn, et al.
Frontiers in Aging Neuroscience|December 17, 2020
Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's DiseaseAnastazja M Gorecki, Megan C Bakeberg, Frances Theunissen, et al.
Pageof 2